Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001829126-25-007885
Filing Date
2025-10-03
Accepted
2025-10-03 17:12:05
Documents
16

Document Format Files

Seq Description Document Type Size
1 S-3 novabay_s3.htm S-3 330220
2 EXHIBIT 5.1 novabay_ex5-1.htm EX-5.1 34969
3 EXHIBIT 23.1 novabay_ex23-1.htm EX-23.1 3671
4 EXHIBIT 107 novabay_ex107.htm   iXBRL EX-FILING FEES 70335
5 GRAPHIC img_001.jpg GRAPHIC 10513
6 GRAPHIC ex5-1_001.jpg GRAPHIC 15574
  Complete submission text file 0001829126-25-007885.txt   636056

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT novabay_ex107_htm.xml XML 20017
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-290712 | Film No.: 251374931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)